| ProductNum | picture | CAS No. | Name and description | Formula | Quick order | 
|---|---|---|---|---|---|
| CL3322 | 
                         | 
                    330829-30-6 | 
                         MRT-10 (MRT 10) 98+%  | 
                    C24H23N3O5S | |
| CL3321 | 
                         | 
                    306387-90-6 | 
                         KAAD-Cyclopamine (Synonyms: Cyclopamine-KAAD;3-Keto-N-aminoethyl-N’-aminocaproyldihydrocinnamoyl Cyclopamine) 98+%  | 
                    C44H63N3O4 | |
| CL3073 | 
                         | 
                    2996821-30-6 | 
                         LM-41 (TEAD Inhibitor) 98+%  | 
                    C19H14FNO2 | |
| CL2397 | 
                         | 
                    127243-85-0 | 
                         H-89 98+%  | 
                    C20 H20 Br N3 O2 S | |
| CL2889 | 
                         | 
                    667463-62-9 | 
                         BIO (GSK-3 Inhibitor IX | 6-bromoindirubin-3-oxime | 6-Bromoindirubin-3'-oxime | MLS 2052 | (2'Z,3'E)-6-Bromoindirubin-3'-oxime | 6-BIO | 6BIO 99+%  | 
                    C16 H10BrN3O2 | |
| CL2888A | 
                         | 
                    905854-03-7 | 
                         (3S,4S)-Tivantinib | 3S,4S)-ARQ 197 | ARQ 198 98+%  | 
                    C23H19N3O2 | |
| CL1006C | 
                         | 
                    2109414-84-6 | 
                         Laduviglusib dihydrochloride | CHIR-99021 dihydrochloride | CT99021 dihydrochloride 98+%  | 
                    C22H18Cl2N8·2HCl | |
| CL2733A | 
                         | 
                    2109704-99-4 | 
                         Belumosudil mesylate (KD025 mesylate; SLx-2119 mesylate) 98+%  | 
                    C27H28N6O5S | |
| CL2709 | 
                         | 
                    1422144-42-0 | 
                         Netarsudil dimesylate ( AR-13324 dimesylate) 98+%  | 
                    C30H35N3O9S2 | |
| CL2506 | 
                         | 
                    40391-99-9 | 
                         Pamidronic Acid 98+%  | 
                    C3H11NO7P2 | |
| CL2425 | 
                         | 
                    425386-60-3 | 
                         Semagacestat | LY450139 98+%  | 
                    C19H27N3O4 | |
| CLA1355 | 
                         | 
                    1447814-75-6 | 
                         Brontictuzumab (Anti-NOTCH1) 95+%  | 
                    — | |
| CLA1337 | 
                         | 
                    1345009-45-1 | 
                         Vantictumab (Anti-FZD) 95+%  | 
                    — | |
| CLA1334 | 
                         | 
                    1359940-55-8 | 
                         Tarextumab (Anti-NOTCH3) 95+%  | 
                    — | |
| CLA1299 | 
                         | 
                    1243262-17-0 | 
                         Demcizumab (Anti-DLL4) 95+%  | 
                    — | |
| CL2221 | 
                         | 
                    1226056-71-8 | 
                         Thiazovivin 98+%  | 
                    C15H13N5OS | |
| CL2213 | 
                         | 
                    686770-61-6 | 
                         N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2- d ]pyrimidin-2-yl)thio]-acetamide; IWP-2 98+%  | 
                    C22H18N4O2S3 | |
| CL1172 | 
                         | 
                    331752-47-7 | 
                         Y27632 HCl hydrate | (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide Dihydrochloride Monohydrate | Y-27632 Dihydrochloride Monohydrate 98+%  | 
                    C14H25Cl2N3O2 | |
| CL1621 | 
                         | 
                    865854-05-3 | 
                         Tideglusib (Synonyms: NP031112; NP-12) 98+%  | 
                    C19H14N2O2S | |
| CL1037 | 
                         | 
                    879085-55-9 | 
                         Vismodegib (Synonyms: GDC-0449) 98+%  | 
                    C19H14Cl2N2O3S | |